Latest news articles

Added 4 years ago Drug news

Pabal (carbetocin) new formulation approved through EU Mutual Recognition Procedure for prevention of uterine atony and postpartum haemorrhage - Ferring

Ferring announced that its new room-temperature-stable formulation of Pabal (carbetocin) for intravenous (IV) administration has been approved through the EU...

Added 4 years ago Drug news

FDA approves additional indication for Evarrest (fibrin sealant patch) for bleeding control during liver surgery-Ethicon

The FDA has approved an additional indication for Ethicon's Evarrest (fibrin sealant patch), as an adjunct to hemostasis for control...

Search all news articles for Haemorrhage during pregnancy
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

Guidelines

A practical guideline for the haematological management of major haemorrhage

The aim of these updated guidelines is to provide recommendations for the haematological management of major haemorrhage in any clinical situation...

Added 4 years ago

Antepartum Haemorrhage

Antepartum haemorrhage (APH) is defined as bleeding from or in to the genital tract, occurring from 24+0 weeks of pregnancy and prior to the birth of the baby.

Added 8 years ago

Search all guidelines for Haemorrhage during pregnancy
 

Journal articles

Cryoprecipitate therapy.

Cryoprecipitate, originally developed as a therapy for patients with antihaemophilic factor deficiency, or haemophilia A, has been in use for almost 50 yr. However, cryoprecipitate is no longer administered according to its original purpose...

Added 1 month ago

The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia.

Massive obstetric haemorrhage remains a major cause of maternal death attributable to hypofibrinogenaemia. Transfusion of large volumes of fresh frozen plasma (FFP) is required to normalise fibrinogen levels.

Added 1 month ago

Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage.

We compared blood component requirements during major obstetric haemorrhage, following the introduction of fibrinogen concentrate. A prospective study of transfusion requirements and patient outcomes was performed for 12 months...

Added 1 month ago

Search all journal articles for Haemorrhage during pregnancy